nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—STK10—renal vein—nephrolithiasis	0.0635	0.125	CbGeAlD
Crizotinib—STK10—renal artery—nephrolithiasis	0.0427	0.0843	CbGeAlD
Crizotinib—Localised oedema—Hydrochlorothiazide—nephrolithiasis	0.0317	0.154	CcSEcCtD
Crizotinib—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.0229	0.111	CcSEcCtD
Crizotinib—INSRR—renal system—nephrolithiasis	0.0188	0.0371	CbGeAlD
Crizotinib—INSRR—kidney—nephrolithiasis	0.0182	0.0358	CbGeAlD
Crizotinib—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0792	CcSEcCtD
Crizotinib—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00974	0.0472	CcSEcCtD
Crizotinib—PRKD1—nephron tubule—nephrolithiasis	0.00834	0.0165	CbGeAlD
Crizotinib—NEK9—renal system—nephrolithiasis	0.00832	0.0164	CbGeAlD
Crizotinib—NEK9—kidney—nephrolithiasis	0.00804	0.0159	CbGeAlD
Crizotinib—PRKD1—renal system—nephrolithiasis	0.00758	0.015	CbGeAlD
Crizotinib—SIK2—renal system—nephrolithiasis	0.00748	0.0148	CbGeAlD
Crizotinib—PRKD1—kidney—nephrolithiasis	0.00733	0.0145	CbGeAlD
Crizotinib—PRKD3—renal system—nephrolithiasis	0.00729	0.0144	CbGeAlD
Crizotinib—PRKD3—kidney—nephrolithiasis	0.00704	0.0139	CbGeAlD
Crizotinib—DSTYK—cortex of kidney—nephrolithiasis	0.0067	0.0132	CbGeAlD
Crizotinib—MET—renal system—nephrolithiasis	0.0063	0.0124	CbGeAlD
Crizotinib—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00614	0.0297	CcSEcCtD
Crizotinib—CDK7—renal system—nephrolithiasis	0.00609	0.012	CbGeAlD
Crizotinib—MET—kidney—nephrolithiasis	0.00609	0.012	CbGeAlD
Crizotinib—ACVR1B—renal system—nephrolithiasis	0.00582	0.0115	CbGeAlD
Crizotinib—ACVR1B—kidney—nephrolithiasis	0.00563	0.0111	CbGeAlD
Crizotinib—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0272	CcSEcCtD
Crizotinib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00529	0.0256	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00524	0.0254	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0249	CcSEcCtD
Crizotinib—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0249	CcSEcCtD
Crizotinib—TESK1—nephron tubule—nephrolithiasis	0.00512	0.0101	CbGeAlD
Crizotinib—IGF1R—renal system—nephrolithiasis	0.00495	0.00977	CbGeAlD
Crizotinib—NUAK2—nephron tubule—nephrolithiasis	0.00486	0.00958	CbGeAlD
Crizotinib—FER—cortex of kidney—nephrolithiasis	0.00485	0.00958	CbGeAlD
Crizotinib—ACVR1—nephron tubule—nephrolithiasis	0.00482	0.00951	CbGeAlD
Crizotinib—IGF1R—kidney—nephrolithiasis	0.00479	0.00945	CbGeAlD
Crizotinib—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0047	0.0228	CcSEcCtD
Crizotinib—AURKA—renal system—nephrolithiasis	0.0047	0.00926	CbGeAlD
Crizotinib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00467	0.0226	CcSEcCtD
Crizotinib—TESK1—renal system—nephrolithiasis	0.00466	0.00919	CbGeAlD
Crizotinib—AURKA—kidney—nephrolithiasis	0.00454	0.00896	CbGeAlD
Crizotinib—STK3—cortex of kidney—nephrolithiasis	0.00454	0.00895	CbGeAlD
Crizotinib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0218	CcSEcCtD
Crizotinib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00439	0.0213	CcSEcCtD
Crizotinib—TESK1—cortex of kidney—nephrolithiasis	0.00438	0.00865	CbGeAlD
Crizotinib—ACVR1—renal system—nephrolithiasis	0.00438	0.00865	CbGeAlD
Crizotinib—RIPK2—nephron tubule—nephrolithiasis	0.00436	0.00859	CbGeAlD
Crizotinib—ACVR1—kidney—nephrolithiasis	0.00424	0.00836	CbGeAlD
Crizotinib—LIMK2—cortex of kidney—nephrolithiasis	0.00417	0.00823	CbGeAlD
Crizotinib—NUAK2—cortex of kidney—nephrolithiasis	0.00416	0.0082	CbGeAlD
Crizotinib—MAP3K2—nephron tubule—nephrolithiasis	0.00413	0.00815	CbGeAlD
Crizotinib—ACVR1—cortex of kidney—nephrolithiasis	0.00413	0.00814	CbGeAlD
Crizotinib—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0198	CcSEcCtD
Crizotinib—PTK2—nephron tubule—nephrolithiasis	0.00404	0.00798	CbGeAlD
Crizotinib—TBK1—nephron tubule—nephrolithiasis	0.00404	0.00798	CbGeAlD
Crizotinib—TYK2—nephron tubule—nephrolithiasis	0.00402	0.00793	CbGeAlD
Crizotinib—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.004	0.0194	CcSEcCtD
Crizotinib—PTK2B—renal system—nephrolithiasis	0.00399	0.00788	CbGeAlD
Crizotinib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00396	0.0192	CcSEcCtD
Crizotinib—IRAK1—nephron tubule—nephrolithiasis	0.00396	0.00782	CbGeAlD
Crizotinib—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00388	0.0188	CcSEcCtD
Crizotinib—PTK2B—kidney—nephrolithiasis	0.00386	0.00762	CbGeAlD
Crizotinib—SLK—nephron tubule—nephrolithiasis	0.00371	0.00731	CbGeAlD
Crizotinib—EPHB4—nephron tubule—nephrolithiasis	0.00368	0.00726	CbGeAlD
Crizotinib—PTK2—renal system—nephrolithiasis	0.00368	0.00725	CbGeAlD
Crizotinib—TBK1—renal system—nephrolithiasis	0.00368	0.00725	CbGeAlD
Crizotinib—TYK2—renal system—nephrolithiasis	0.00365	0.00721	CbGeAlD
Crizotinib—CYP3A4—urine—nephrolithiasis	0.00362	0.00715	CbGeAlD
Crizotinib—EPHA2—nephron tubule—nephrolithiasis	0.00361	0.00712	CbGeAlD
Crizotinib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0174	CcSEcCtD
Crizotinib—PTK2—kidney—nephrolithiasis	0.00355	0.00701	CbGeAlD
Crizotinib—TBK1—kidney—nephrolithiasis	0.00355	0.00701	CbGeAlD
Crizotinib—RPS6KB1—renal system—nephrolithiasis	0.00354	0.00698	CbGeAlD
Crizotinib—TYK2—kidney—nephrolithiasis	0.00353	0.00697	CbGeAlD
Crizotinib—MAP3K3—nephron tubule—nephrolithiasis	0.00352	0.00695	CbGeAlD
Crizotinib—TBK1—cortex of kidney—nephrolithiasis	0.00346	0.00683	CbGeAlD
Crizotinib—PTK2—cortex of kidney—nephrolithiasis	0.00346	0.00683	CbGeAlD
Crizotinib—TYK2—cortex of kidney—nephrolithiasis	0.00344	0.00678	CbGeAlD
Crizotinib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00343	0.0166	CcSEcCtD
Crizotinib—RPS6KB1—kidney—nephrolithiasis	0.00342	0.00675	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—nephrolithiasis	0.00339	0.0067	CbGeAlD
Crizotinib—EPHB4—renal system—nephrolithiasis	0.00335	0.0066	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—nephrolithiasis	0.00333	0.00657	CbGeAlD
Crizotinib—JAK2—renal system—nephrolithiasis	0.00332	0.00656	CbGeAlD
Crizotinib—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0033	0.016	CcSEcCtD
Crizotinib—AXL—cortex of kidney—nephrolithiasis	0.0033	0.0065	CbGeAlD
Crizotinib—YES1—nephron tubule—nephrolithiasis	0.00325	0.00642	CbGeAlD
Crizotinib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0157	CcSEcCtD
Crizotinib—EPHB4—kidney—nephrolithiasis	0.00323	0.00638	CbGeAlD
Crizotinib—JAK2—kidney—nephrolithiasis	0.00321	0.00634	CbGeAlD
Crizotinib—TAOK3—nephron tubule—nephrolithiasis	0.00321	0.00634	CbGeAlD
Crizotinib—TEK—renal system—nephrolithiasis	0.0032	0.00632	CbGeAlD
Crizotinib—SLK—cortex of kidney—nephrolithiasis	0.00317	0.00626	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—nephrolithiasis	0.00315	0.00622	CbGeAlD
Crizotinib—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00314	0.0152	CcSEcCtD
Crizotinib—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.0152	CcSEcCtD
Crizotinib—JAK2—cortex of kidney—nephrolithiasis	0.00313	0.00617	CbGeAlD
Crizotinib—TEK—kidney—nephrolithiasis	0.0031	0.00611	CbGeAlD
Crizotinib—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0149	CcSEcCtD
Crizotinib—MAP4K5—cortex of kidney—nephrolithiasis	0.00301	0.00595	CbGeAlD
Crizotinib—TEK—cortex of kidney—nephrolithiasis	0.00301	0.00595	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—nephrolithiasis	0.00301	0.00595	CbGeAlD
Crizotinib—YES1—renal system—nephrolithiasis	0.00296	0.00583	CbGeAlD
Crizotinib—STK10—renal system—nephrolithiasis	0.00293	0.00578	CbGeAlD
Crizotinib—TAOK3—renal system—nephrolithiasis	0.00292	0.00576	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—nephrolithiasis	0.00288	0.00568	CbGeAlD
Crizotinib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00286	0.0139	CcSEcCtD
Crizotinib—YES1—kidney—nephrolithiasis	0.00286	0.00564	CbGeAlD
Crizotinib—SRC—renal system—nephrolithiasis	0.00284	0.00561	CbGeAlD
Crizotinib—STK10—kidney—nephrolithiasis	0.00283	0.00559	CbGeAlD
Crizotinib—TAOK3—kidney—nephrolithiasis	0.00282	0.00557	CbGeAlD
Crizotinib—Shock—Hydrochlorothiazide—nephrolithiasis	0.00281	0.0136	CcSEcCtD
Crizotinib—YES1—cortex of kidney—nephrolithiasis	0.00278	0.00549	CbGeAlD
Crizotinib—SRC—kidney—nephrolithiasis	0.00275	0.00543	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—nephrolithiasis	0.00275	0.00542	CbGeAlD
Crizotinib—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00257	0.0124	CcSEcCtD
Crizotinib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00255	0.0123	CcSEcCtD
Crizotinib—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00252	0.0122	CcSEcCtD
Crizotinib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00249	0.012	CcSEcCtD
Crizotinib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0119	CcSEcCtD
Crizotinib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00245	0.0118	CcSEcCtD
Crizotinib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0109	CcSEcCtD
Crizotinib—ABL1—nephron tubule—nephrolithiasis	0.00222	0.00438	CbGeAlD
Crizotinib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00994	CcSEcCtD
Crizotinib—ABL1—renal system—nephrolithiasis	0.00202	0.00398	CbGeAlD
Crizotinib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00948	CcSEcCtD
Crizotinib—ABL1—kidney—nephrolithiasis	0.00195	0.00385	CbGeAlD
Crizotinib—ABL1—cortex of kidney—nephrolithiasis	0.0019	0.00375	CbGeAlD
Crizotinib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00916	CcSEcCtD
Crizotinib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00881	CcSEcCtD
Crizotinib—Rash—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00873	CcSEcCtD
Crizotinib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00873	CcSEcCtD
Crizotinib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00823	CcSEcCtD
Crizotinib—CYP3A5—nephron tubule—nephrolithiasis	0.0013	0.00257	CbGeAlD
Crizotinib—CYP3A5—renal system—nephrolithiasis	0.00118	0.00233	CbGeAlD
Crizotinib—CYP3A5—kidney—nephrolithiasis	0.00114	0.00225	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—nephrolithiasis	0.00111	0.0022	CbGeAlD
Crizotinib—CYP3A4—renal system—nephrolithiasis	0.000887	0.00175	CbGeAlD
Crizotinib—CYP3A4—kidney—nephrolithiasis	0.000857	0.00169	CbGeAlD
Crizotinib—AXL—Signaling Pathways—RGS14—nephrolithiasis	0.000782	0.00273	CbGpPWpGaD
Crizotinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000777	0.00271	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000762	0.00266	CbGpPWpGaD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00076	0.00265	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—APRT—nephrolithiasis	0.000747	0.00261	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—SLC26A1—nephrolithiasis	0.000747	0.00261	CbGpPWpGaD
Crizotinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000741	0.00259	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ADCY10—nephrolithiasis	0.000735	0.00256	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000715	0.00249	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—SLC7A9—nephrolithiasis	0.000696	0.00243	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—DGKH—nephrolithiasis	0.000696	0.00243	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—RGS14—nephrolithiasis	0.000692	0.00241	CbGpPWpGaD
Crizotinib—ABCB1—nephron tubule—nephrolithiasis	0.000691	0.00136	CbGeAlD
Crizotinib—LCK—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000666	0.00232	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—DGKH—nephrolithiasis	0.000665	0.00232	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000665	0.00232	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ADCY10—nephrolithiasis	0.000665	0.00232	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ADCY10—nephrolithiasis	0.000651	0.00227	CbGpPWpGaD
Crizotinib—PTK2B—BDNF signaling pathway—SPP1—nephrolithiasis	0.000649	0.00226	CbGpPWpGaD
Crizotinib—IRAK1—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.000637	0.00222	CbGpPWpGaD
Crizotinib—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000634	0.00221	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—DGKH—nephrolithiasis	0.000632	0.00221	CbGpPWpGaD
Crizotinib—ABCB1—renal system—nephrolithiasis	0.000628	0.00124	CbGeAlD
Crizotinib—FES—Signaling Pathways—RGS14—nephrolithiasis	0.000625	0.00218	CbGpPWpGaD
Crizotinib—NTRK1—BDNF signaling pathway—SPP1—nephrolithiasis	0.000621	0.00217	CbGpPWpGaD
Crizotinib—ABCB1—kidney—nephrolithiasis	0.000607	0.0012	CbGeAlD
Crizotinib—SRC—FGF signaling pathway—SPP1—nephrolithiasis	0.000604	0.00211	CbGpPWpGaD
Crizotinib—RPS6KB1—BDNF signaling pathway—SPP1—nephrolithiasis	0.000602	0.0021	CbGpPWpGaD
Crizotinib—ABCB1—cortex of kidney—nephrolithiasis	0.000591	0.00117	CbGeAlD
Crizotinib—SRC—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00059	0.00206	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—SLC7A9—nephrolithiasis	0.000569	0.00199	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—DGKH—nephrolithiasis	0.000569	0.00199	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—CHRM3—nephrolithiasis	0.000565	0.00197	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—RGS14—nephrolithiasis	0.000565	0.00197	CbGpPWpGaD
Crizotinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000562	0.00196	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—SLC7A9—nephrolithiasis	0.000562	0.00196	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—DGKH—nephrolithiasis	0.000562	0.00196	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000557	0.00194	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—DGKH—nephrolithiasis	0.000557	0.00194	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000557	0.00194	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000557	0.00194	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—RGS14—nephrolithiasis	0.000553	0.00193	CbGpPWpGaD
Crizotinib—SRC—Integrins in angiogenesis—SPP1—nephrolithiasis	0.000534	0.00186	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—AQP1—nephrolithiasis	0.000533	0.00186	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—DGKH—nephrolithiasis	0.000528	0.00184	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000528	0.00184	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—PTH—nephrolithiasis	0.000517	0.0018	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000515	0.00179	CbGpPWpGaD
Crizotinib—BLK—Focal Adhesion—SPP1—nephrolithiasis	0.000507	0.00177	CbGpPWpGaD
Crizotinib—FGR—Focal Adhesion—SPP1—nephrolithiasis	0.000506	0.00176	CbGpPWpGaD
Crizotinib—IRAK1—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000497	0.00173	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000483	0.00168	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000483	0.00168	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—CHRM3—nephrolithiasis	0.000482	0.00168	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ADCY10—nephrolithiasis	0.000481	0.00168	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—CHRM3—nephrolithiasis	0.000481	0.00168	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—DGKH—nephrolithiasis	0.000467	0.00163	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—CHRM3—nephrolithiasis	0.000457	0.00159	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—PTH—nephrolithiasis	0.00044	0.00153	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—RGS14—nephrolithiasis	0.000439	0.00153	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000428	0.00149	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000422	0.00147	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—DGKH—nephrolithiasis	0.000422	0.00147	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000422	0.00147	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—SLC7A9—nephrolithiasis	0.000419	0.00146	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—DGKH—nephrolithiasis	0.000419	0.00146	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—PTH—nephrolithiasis	0.000418	0.00146	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—SLC7A9—nephrolithiasis	0.000417	0.00145	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—DGKH—nephrolithiasis	0.000417	0.00145	CbGpPWpGaD
Crizotinib—PTK2—Focal Adhesion—SPP1—nephrolithiasis	0.000414	0.00144	CbGpPWpGaD
Crizotinib—CDK7—Disease—SLC26A1—nephrolithiasis	0.000413	0.00144	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—RGS14—nephrolithiasis	0.000409	0.00142	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000404	0.00141	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000403	0.0014	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—CHRM3—nephrolithiasis	0.000403	0.0014	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—DGKH—nephrolithiasis	0.000392	0.00137	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—SLC7A9—nephrolithiasis	0.000392	0.00137	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000392	0.00137	CbGpPWpGaD
Crizotinib—TYK2—Signaling by PDGF—SPP1—nephrolithiasis	0.000389	0.00136	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—CHRM3—nephrolithiasis	0.000382	0.00133	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000382	0.00133	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—DGKH—nephrolithiasis	0.000382	0.00133	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—DGKH—nephrolithiasis	0.000374	0.0013	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000374	0.0013	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000372	0.0013	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—PTH—nephrolithiasis	0.000368	0.00128	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—PTH—nephrolithiasis	0.000368	0.00128	CbGpPWpGaD
Crizotinib—CDK7—Disease—ATP6V0A4—nephrolithiasis	0.000368	0.00128	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000367	0.00128	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—RGS14—nephrolithiasis	0.000364	0.00127	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—RGS14—nephrolithiasis	0.000359	0.00125	CbGpPWpGaD
Crizotinib—JAK2—BDNF signaling pathway—SPP1—nephrolithiasis	0.000356	0.00124	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—PTH—nephrolithiasis	0.000349	0.00122	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000349	0.00122	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000344	0.0012	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—SLC7A9—nephrolithiasis	0.000343	0.0012	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—DGKH—nephrolithiasis	0.000343	0.0012	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—PTH—nephrolithiasis	0.00034	0.00119	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000338	0.00118	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000336	0.00117	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—RGS14—nephrolithiasis	0.000333	0.00116	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—RGS14—nephrolithiasis	0.000333	0.00116	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ADCY10—nephrolithiasis	0.000332	0.00116	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—PTH—nephrolithiasis	0.000319	0.00111	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000314	0.0011	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—PTH—nephrolithiasis	0.000309	0.00108	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—CHRM3—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000304	0.00106	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000304	0.00106	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—DGKH—nephrolithiasis	0.000304	0.00106	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—SLC7A9—nephrolithiasis	0.000304	0.00106	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—DGKH—nephrolithiasis	0.000297	0.00103	CbGpPWpGaD
Crizotinib—JAK2—Signaling by PDGF—SPP1—nephrolithiasis	0.000295	0.00103	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000295	0.00103	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RGS14—nephrolithiasis	0.000286	0.000997	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RGS14—nephrolithiasis	0.000282	0.000983	CbGpPWpGaD
Crizotinib—TYK2—Disease—SLC26A1—nephrolithiasis	0.000281	0.000979	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—PTH—nephrolithiasis	0.000279	0.000973	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000276	0.000962	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—DGKH—nephrolithiasis	0.000276	0.000962	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CHRM3—nephrolithiasis	0.000276	0.000962	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—SPP1—nephrolithiasis	0.000276	0.000961	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000271	0.000945	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CHRM3—nephrolithiasis	0.00027	0.000942	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RGS14—nephrolithiasis	0.000267	0.000932	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—SPP1—nephrolithiasis	0.00026	0.000905	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RGS14—nephrolithiasis	0.00026	0.000905	CbGpPWpGaD
Crizotinib—LCK—Signaling by PDGF—SPP1—nephrolithiasis	0.000258	0.0009	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—PTH—nephrolithiasis	0.000252	0.00088	CbGpPWpGaD
Crizotinib—TYK2—Disease—ATP6V0A4—nephrolithiasis	0.00025	0.000873	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000248	0.000864	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000248	0.000864	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000248	0.000864	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ADCY10—nephrolithiasis	0.000247	0.000862	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—PTH—nephrolithiasis	0.000247	0.000861	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—DGKH—nephrolithiasis	0.000246	0.000858	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000246	0.000858	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000242	0.000845	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—DGKH—nephrolithiasis	0.000242	0.000845	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—DGKH—nephrolithiasis	0.000232	0.000809	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000232	0.000809	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000231	0.000807	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—SPP1—nephrolithiasis	0.000229	0.000797	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000225	0.000785	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—DGKH—nephrolithiasis	0.000225	0.000785	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—DGKH—nephrolithiasis	0.000225	0.000784	CbGpPWpGaD
Crizotinib—SRC—Focal Adhesion—SPP1—nephrolithiasis	0.000221	0.00077	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—SPP1—nephrolithiasis	0.000221	0.000769	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000215	0.000748	CbGpPWpGaD
Crizotinib—JAK2—Disease—SLC26A1—nephrolithiasis	0.000213	0.000742	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RGS14—nephrolithiasis	0.00021	0.000733	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADCY10—nephrolithiasis	0.000203	0.000706	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CHRM3—nephrolithiasis	0.0002	0.000696	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RGS14—nephrolithiasis	0.000197	0.000686	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—PTH—nephrolithiasis	0.000196	0.000684	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—DGKH—nephrolithiasis	0.000193	0.000673	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000193	0.000673	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—DGKH—nephrolithiasis	0.00019	0.000664	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00019	0.000664	CbGpPWpGaD
Crizotinib—JAK2—Disease—ATP6V0A4—nephrolithiasis	0.00019	0.000662	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000188	0.000655	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000188	0.000655	CbGpPWpGaD
Crizotinib—LCK—Disease—SLC26A1—nephrolithiasis	0.000186	0.00065	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000185	0.000645	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—SPP1—nephrolithiasis	0.000185	0.000645	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PTH—nephrolithiasis	0.000183	0.000636	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—DGKH—nephrolithiasis	0.000181	0.00063	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000181	0.00063	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADCY10—nephrolithiasis	0.000179	0.000625	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000179	0.000624	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CHRM3—nephrolithiasis	0.000178	0.00062	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—DGKH—nephrolithiasis	0.000175	0.000611	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000175	0.000611	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000175	0.000611	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—SPP1—nephrolithiasis	0.000175	0.000611	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000175	0.000609	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000175	0.000609	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RGS14—nephrolithiasis	0.000172	0.000601	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000168	0.000585	CbGpPWpGaD
Crizotinib—LCK—Disease—ATP6V0A4—nephrolithiasis	0.000166	0.000579	CbGpPWpGaD
Crizotinib—SRC—Disease—SLC26A1—nephrolithiasis	0.000165	0.000575	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—PTH—nephrolithiasis	0.000164	0.000571	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000163	0.000567	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PTH—nephrolithiasis	0.000163	0.000567	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000163	0.000567	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PTH—nephrolithiasis	0.00016	0.000559	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—SPP1—nephrolithiasis	0.00016	0.000559	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000156	0.000543	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000156	0.000543	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PTH—nephrolithiasis	0.000153	0.000535	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RGS14—nephrolithiasis	0.000153	0.000532	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PTH—nephrolithiasis	0.000149	0.000519	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—PTH—nephrolithiasis	0.000149	0.000519	CbGpPWpGaD
Crizotinib—SRC—Disease—ATP6V0A4—nephrolithiasis	0.000147	0.000513	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000143	0.000499	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000142	0.000495	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—DGKH—nephrolithiasis	0.000142	0.000495	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SPP1—nephrolithiasis	0.00014	0.000489	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CHRM3—nephrolithiasis	0.00014	0.000487	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CHRM3—nephrolithiasis	0.000138	0.00048	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000133	0.000463	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—DGKH—nephrolithiasis	0.000133	0.000463	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000131	0.000455	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTH—nephrolithiasis	0.000128	0.000445	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000127	0.000444	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CHRM3—nephrolithiasis	0.000127	0.000442	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SPP1—nephrolithiasis	0.000127	0.000442	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTH—nephrolithiasis	0.000126	0.000439	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000124	0.000434	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SPP1—nephrolithiasis	0.000124	0.000432	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PTH—nephrolithiasis	0.000119	0.000416	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—DGKH—nephrolithiasis	0.000116	0.000406	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000116	0.000406	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTH—nephrolithiasis	0.000116	0.000404	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000108	0.000378	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000108	0.000378	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000108	0.000376	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000103	0.000359	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—DGKH—nephrolithiasis	0.000103	0.000359	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CHRM3—nephrolithiasis	0.000103	0.000358	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGXT—nephrolithiasis	9.62e-05	0.000335	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CHRM3—nephrolithiasis	9.61e-05	0.000335	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTH—nephrolithiasis	9.39e-05	0.000327	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SPP1—nephrolithiasis	9.16e-05	0.00032	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTH—nephrolithiasis	8.79e-05	0.000306	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CHRM3—nephrolithiasis	8.41e-05	0.000293	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APRT—nephrolithiasis	8.18e-05	0.000285	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SLC26A1—nephrolithiasis	8.18e-05	0.000285	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SPP1—nephrolithiasis	8.17e-05	0.000285	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SPP1—nephrolithiasis	8.05e-05	0.000281	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AQP1—nephrolithiasis	7.72e-05	0.000269	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SPP1—nephrolithiasis	7.7e-05	0.000269	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTH—nephrolithiasis	7.69e-05	0.000268	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SPP1—nephrolithiasis	7.47e-05	0.00026	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CHRM3—nephrolithiasis	7.45e-05	0.00026	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CHRM3—nephrolithiasis	6.98e-05	0.000244	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTH—nephrolithiasis	6.81e-05	0.000238	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	6.65e-05	0.000232	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SPP1—nephrolithiasis	6.41e-05	0.000223	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SPP1—nephrolithiasis	6.32e-05	0.00022	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SPP1—nephrolithiasis	5.99e-05	0.000209	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGXT—nephrolithiasis	5.93e-05	0.000207	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AQP1—nephrolithiasis	5.83e-05	0.000203	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SPP1—nephrolithiasis	5.82e-05	0.000203	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CHRM3—nephrolithiasis	5.27e-05	0.000184	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	5.04e-05	0.000176	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APRT—nephrolithiasis	5.04e-05	0.000176	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SPP1—nephrolithiasis	4.71e-05	0.000164	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SPP1—nephrolithiasis	4.41e-05	0.000154	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SPP1—nephrolithiasis	3.86e-05	0.000135	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AQP1—nephrolithiasis	3.59e-05	0.000125	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SPP1—nephrolithiasis	3.42e-05	0.000119	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	3.25e-05	0.000113	CbGpPWpGaD
